Stockscreener 앱 받기
9.91
8.66%
0.79
시간 외 거래:
9.91
전일 마감가:
$9.12
열려 있는:
$9.17
하루 거래량:
830.33K
Relative Volume:
1.02
시가총액:
$757.61M
수익:
$54.55M
순이익/손실:
$-193.57M
주가수익비율:
-3.4291
EPS:
-2.89
순현금흐름:
$-181.86M
1주 성능:
+6.10%
1개월 성능:
-12.38%
6개월 성능:
-30.55%
1년 성능:
-59.45%
1일 변동 폭
$9.17
$10.03
1주일 범위
$8.97
$10.03
52주 변동 폭
$8.18
$29.56
누릭스 테라퓨틱스 Stock (NRIX) Company Profile
명칭
Nurix Therapeutics Inc
전화
(415) 660-5320
주소
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
NRIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
9.91 | 697.22M | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
누릭스 테라퓨틱스 Stock (NRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-17 | 개시 | Leerink Partners | Market Perform |
| 2024-12-10 | 개시 | BTIG Research | Buy |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-11 | 개시 | Jefferies | Buy |
| 2024-09-06 | 재개 | Robert W. Baird | Outperform |
| 2024-07-31 | 개시 | Truist | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2023-03-09 | 개시 | Barclays | Overweight |
| 2023-02-28 | 개시 | Oppenheimer | Outperform |
| 2022-10-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | 개시 | Wells Fargo | Equal Weight |
| 2021-12-29 | 개시 | H.C. Wainwright | Buy |
| 2021-10-14 | 개시 | SVB Leerink | Outperform |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-04-30 | 재개 | Piper Sandler | Overweight |
| 2021-04-30 | 개시 | RBC Capital Mkts | Outperform |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2020-11-19 | 개시 | Robert W. Baird | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
| 2020-08-18 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-18 | 개시 | Stifel | Buy |
모두보기
누릭스 테라퓨틱스 주식(NRIX)의 최신 뉴스
Applying Elliott Wave Theory to Nurix Therapeutics Inc.Long Setup & Risk Controlled Daily Trade Plans - Newser
Does Nurix Therapeutics Inc. show high probability of reboundRisk Management & Daily Risk Controlled Trade Plans - Newser
Using economic indicators to assess Nurix Therapeutics Inc. potentialQuarterly Risk Review & Daily Price Action Insights - Newser
What high frequency data says about Nurix Therapeutics Inc.July 2025 Macro Moves & Smart Allocation Stock Reports - Newser
Market reaction to Nurix Therapeutics Inc.’s recent news2025 Key Lessons & Growth Focused Entry Reports - Newser
Invesco Ltd. Increases Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Walleye Capital LLC Invests $880,000 in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Applying Wyckoff theory to Nurix Therapeutics Inc. stockMarket Performance Recap & Stock Timing and Entry Methods - Newser
Key resistance and support levels for Nurix Therapeutics Inc.Market Performance Report & Daily Risk Controlled Trade Plans - Newser
Published on: 2025-09-05 13:16:55 - Newser
Is it time to cut losses on Nurix Therapeutics Inc.2025 Market Sentiment & Free Safe Capital Growth Stock Tips - Newser
Will breakout in Nurix Therapeutics Inc. lead to full recoveryJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser
What to do if you’re stuck in Nurix Therapeutics Inc.July 2025 Momentum & Accurate Trade Setup Notifications - Newser
Analyzing Nurix Therapeutics Inc. with multi timeframe chartsMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - Newser
Is this a good reentry point in Nurix Therapeutics Inc.July 2025 Outlook & Daily Entry Point Alerts - Newser
Combining machine learning predictions for Nurix Therapeutics Inc.Bear Alert & Risk Managed Investment Strategies - Newser
Driehaus Capital Management LLC Sells 563,751 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Analyzing drawdowns of Nurix Therapeutics Inc. with statistical toolsMarket Trend Report & Growth-Oriented Investment Plans - Newser
Sector ETF performance correlation with Nurix Therapeutics Inc.2025 Institutional Moves & High Yield Stock Recommendations - Newser
Nuveen LLC Makes New Investment in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics, Inc. $NRIX Shares Sold by Redmile Group LLC - MarketBeat
Nurix Therapeutics, Inc. $NRIX Shares Bought by Vestal Point Capital LP - MarketBeat
Tema Etfs LLC Increases Stake in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Understanding Nurix Therapeutics Inc.’s price movementJuly 2025 Catalysts & Detailed Earnings Play Strategies - Newser
Technical signs of recovery in Nurix Therapeutics Inc.2025 Technical Patterns & Precise Buy Zone Identification - Newser
Visual analytics tools that track Nurix Therapeutics Inc. performancePrice Action & Free Technical Confirmation Trade Alerts - Newser
What machine learning models say about Nurix Therapeutics Inc.2025 Price Momentum & High Return Stock Watch Alerts - Newser
Applying big data sentiment scoring on Nurix Therapeutics Inc.2025 Big Picture & Fast Gaining Stock Reports - Newser
Nurix Therapeutics to Discuss Bexobrutideg Developments - TipRanks
Using R and stats models for Nurix Therapeutics Inc. forecastingGold Moves & Short-Term Trading Alerts - Newser
What’s the recovery path for long term holders of Nurix Therapeutics Inc.July 2025 WrapUp & Fast Gain Swing Alerts - Newser
Sentiment analysis tools applied to Nurix Therapeutics Inc.Trade Volume Summary & Weekly Top Gainers Alerts - Newser
Russell Investments Group Ltd. Buys 93,993 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Statistical indicators supporting Nurix Therapeutics Inc.’s strengthGap Down & Daily Profit Maximizing Tips - Newser
Visualizing Nurix Therapeutics Inc. stock with heatmapsJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - Newser
What technical models suggest about Nurix Therapeutics Inc.’s comeback2025 Technical Overview & Weekly Watchlist for Hot Stocks - Newser
누릭스 테라퓨틱스 (NRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):